Study of the influenza virus vaccine, trivalent, types A & B, live cold-adapted in a community-based, non-randomized, open-label trial in children to assess safety and herd immunity for the control of epidemic influenza

Trial Profile

Study of the influenza virus vaccine, trivalent, types A & B, live cold-adapted in a community-based, non-randomized, open-label trial in children to assess safety and herd immunity for the control of epidemic influenza

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Nov 2005

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top